- Home
- MRUS vs BL Comparison
MRUS vs BL Comparison
Compare MRUS & BL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- BL
- Stock Information
- Founded
- MRUS 2003
- BL 2001
- Country
- MRUS Netherlands
- BL United States
- Employees
- MRUS N/A
- BL N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- BL Computer Software: Prepackaged Software
- Sector
- MRUS Health Care
- BL Technology
- Exchange
- MRUS Nasdaq
- BL Nasdaq
- Market Cap
- MRUS 3.6B
- BL 3.7B
- IPO Year
- MRUS 2016
- BL 2016
- Fundamental
- Price
- MRUS $46.58
- BL $59.17
- Analyst Decision
- MRUS Strong Buy
- BL Hold
- Analyst Count
- MRUS 10
- BL 12
- Target Price
- MRUS $86.70
- BL $63.60
- AVG Volume (30 Days)
- MRUS 376.4K
- BL 639.8K
- Earning Date
- MRUS 10-31-2024
- BL 11-07-2024
- Dividend Yield
- MRUS N/A
- BL N/A
- EPS Growth
- MRUS N/A
- BL 45.65
- EPS
- MRUS N/A
- BL 0.98
- Revenue
- MRUS $35,932,000.00
- BL $639,606,000.00
- Revenue This Year
- MRUS N/A
- BL $13.37
- Revenue Next Year
- MRUS $52.49
- BL $9.54
- P/E Ratio
- MRUS N/A
- BL $60.51
- Revenue Growth
- MRUS N/A
- BL 11.39
- 52 Week Low
- MRUS $22.26
- BL $43.37
- 52 Week High
- MRUS $61.61
- BL $69.31
- Technical
- Relative Strength Index (RSI)
- MRUS 32.37
- BL 59.61
- Support Level
- MRUS $48.42
- BL $60.25
- Resistance Level
- MRUS $53.49
- BL $63.11
- Average True Range (ATR)
- MRUS 2.17
- BL 1.74
- MACD
- MRUS -0.54
- BL 0.22
- Stochastic Oscillator
- MRUS 5.73
- BL 65.96
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About BL BlackLine Inc.
BlackLine Inc is engaged in providing financial accounting close solutions delivered as Software as a Service (SaaS). The Company's solutions enable its customers to address various aspects of their financial close process including account reconciliations, variance analysis of account balances, journal entry capabilities, and certain types of data matching capabilities. The majority of the revenue of the company is earned in the United States.